The main aim of oncologists worldwide is to understand and then intervene in the primary tumor initiation and propagation mechanisms. This is essential to allow targeted elimination of cancer cells without altering normal mitotic cells. Currently, there are two main rival theories describing the process of tumorigenesis. According to the Stochastic Model, potentially any cell, once defunct, is capable of initiating carcinogenesis. Alternatively the Cancer Stem Cell (CSC) Model posits that only a small fraction of undifferentiated tumor cells are capable of triggering carcinogenesis. Like healthy stem cells, CSCs are also characterized by a capacity for self-renewal and the ability to generate differentiated progeny, possibly mediating treatment resistance, thus leading to tumor recurrence and metastasis. Moreover, molecular signaling profiles are similar between CSCs and normal stem cells, including Wnt, Notch and Hedgehog pathways. Therefore, development of novel chemotherapeutic agents and proteins (e.g., enzymes and antibodies) specifically targeting CSCs are attractive pharmaceutical candidates. This article describes small molecule inhibitors of stem cell pathways Wnt, Notch and Hedgehog, and their recent chemotherapy clinical trials.
We carried out an analysis of the total incidence of colon cancer throughout Kazakhstan. Retrospectively, according to the regional reports on endoscopic screening, the study showed an increase in the age-related incidence of colorectal cancer (CRC) cases from 2004-2008 to 2009-2014. The peak of morbidity in both periods was noted in the age category of >70 years. The indicators of the territorial distribution of CRC incidence make it possible to divide the regions into areas with low or high rates of CRC. Specific indicators showed newly diagnosed cases of CRC stages I, II, III, and IV in 2004-2018. The incidence rates of stages I and II showed a two-fold increase (35%-67.4%) and the incidence of stage IV showed a decline from 19.3% to 13.1% and of stage III from 45.7% to 19.5% from 2004 to 2018, respectively. An analysis of CRC incidence throughout Kazakhstan showed an increase in the overall incidence. Since population-based CRC screening was introduced in 2011, the morbidity was found to increase for stages I and II.
28 November 2022 in Case Reports in Gastroenterology
Oral manifestations of IBD can be specific or nonspecific, due to intestinal malabsorption or induced by pharmacological treatments. Oral manifestations may precede the diagnosis of IBD or interfere with timely diagnosis and treatment. The paradigm of treatment for oral lesions in patients with IBD is based on treating and controlling the intestinal manifestations of the underlying disease as well as local methods of treatment can be used. Here, we report a case of a patient with the oral manifestation of IBD, who responded to treatment with infliximab. The patient was admitted with complaints of long-term nonhealing ulcers of the lips and oral cavity, odynophagia, and there were no intestinal manifestations at that time. The appearance of the disease in 2008 with lesions of the oral cavity, however, Crohn’s disease was diagnosed in 2016. The patient began therapy with azathioprine and prednisolone, and later developed hormone dependence and osteoporosis. In 2020, against the background of immunosuppressive therapy, the patient has an exacerbation, especially increased symptoms from the lesion of the oral cavity. In 2020 was started therapy with vedolizumab, with slight improvement. Due to the ineffectiveness of the latter’s therapy, therapy with monoclonal antibodies (infliximab) was started in February 2021. Currently, patient is in clinical, laboratory, and endoscopic remission.
1 January 2020 in Respiratory Medicine Case Reports
A 58-year-old male patient with a bronchopleural fistula underwent endoscopic installation of an occluder at the mouth of the fistula. The fistula was located in the stump of the main bronchus of the right lung after a pulmonectomy in 2019. During medical bronchoscopy, mucopurulent contents were actively received from the mouth of the fistula. To close the fistula, the patient was simultaneously drained of the pleural cavity by Bulau and installed an occluder from an improvised tool designed for cleaning the endoscope's biopsy channel. In dynamics, purulent contents do not come from the mouth of the fistula and the liquid content in the pleural cavity has significantly decreased. The patient with improved General condition was discharged for observation at the place of residence.
1 January 2024 in Diagnostic and Interventional Endoscopy
Gastric antral vascular ectasia (GAVE) syndrome is a rare but clinically significant cause of gastrointestinal bleeding. Gastric antral vascular ectasia syndrome may be asymptomatic or accompanied by a clinical picture of anemia or obvious gastrointestinal bleeding. Gastric antral vascular ectasia syndrome is diagnosed by a characteristic endoscopic picture presented by the so-called watermelon stomach with a typical localization of changes in the antrum. Argon plasma coagulation (APC) is a new method of contactless electrocoagulation. In this article, we present 2 cases of successful treatment of patients with GAVE syndrome using argonoplasmic coagulation. Both patients had a positive endoscopic response after 2 sessions of APC and a stable increase in hemoglobin levels. After 12 months of follow-up, the patients had no relapses. No serious complications were reported. Argon plasma coagulation is a safe and effective treatment for vascular malformations of the stomach. Even though the argon plasma complex is financially expensive, it takes a short period to master the technique of using the argon plasma complex in outpatient settings.
Background: By analyzing small bowel capsule endoscopy (SBCE) performed in two large hospitals in Kazakhstan, we aimed to explore the characteristics of patients representative of Central Asia and the technical characteristics of SBCE.Methods: SBCE cases were retrospectively analyzed. A descriptive analysis was conducted on the patients’ demographic data, diagnosis, and clinical symptoms. The results of SBCE, such as the lesions found, transit time and retention rate in the stomach and small bowel, and bowel visualization quality, were analyzed. Complications related to SBCE were investigated.Results: SBCE was performed in 123 patients. Abdominal pain (81.3%) and chronic diarrhea (66.7%) were the most common symptoms, followed by weight loss (25.2%) and gastrointestinal bleeding (15.4%). The most common disease was Crohn’s disease (52.0%). Definite lesions, such as ulcers, polyps, and bleeding, were identified in 55.3% of patients. SBCE was successfully completed in all cases except for 11 (9.1%). The average small bowel transit time was 4 hours and 28 minutes. Excellent visualization (>75% of mucosa) was reported in 82.5% of patients. No patients experienced complications.Conclusions: SBCE performed in Kazakhstan showed a high diagnostic yield with high-quality patient selection and no complications.